Supplements Guide · A critical assessment

Probiotics: worthwhile help or an expensive placebo?

Billions of bacteria per capsule, big promises on the pack. What studies show, why the strain name matters more than the bacterial count and when the cause lies somewhere else entirely.

Strain, not count Cochrane and guidelines Gut-immune axis Risks KPNI view
SJ Shukri Jarmoukli · Physician, Integrative Medicine
ViveCura Berlin
My starting point

I have nothing against probiotics. I do have something against probiotics taken for no reason. A bacterium without a strain name is a promise with no return address.

I bet you know this shelf. White, green, golden tubs. On them, numbers like 20 billion, 50 billion, 100 billion. Next to them, words like gut flora, immune system, wellbeing.

Maybe you have been taking a capsule for months. Every morning, reliably. And when someone asks whether it does anything for you, you hesitate for a moment. Maybe. Hard to say.

May I ask you an uncomfortable question? Do you know which strain is in your capsule? Not the genus. The strain.

If you have to go and check first, you are in very good company. That is exactly where this article begins.

Probiotics are a market worth billions, and their use has risen worldwide. At the same time, studies deliver contradictory results for many strains and products. This comes not from an outside critic, but from a team at the Weizmann Institute in Israel that itself researches probiotics intensively.

In this text, I am not trying to talk probiotics down. It is about sorting things out honestly. Where does the evidence hold up? Where is it thin? And where is it worth looking at entirely different causes?

The short answer

Probiotics can be worthwhile, but only in specific situations and with specific, studied strains. The best evidence is for protection against diarrhoea during a course of antibiotics. In healthy people, probiotics did not measurably change the diversity of the gut flora in studies, and in irritable bowel syndrome (IBS) the evidence is uncertain. What matters is the full strain name, not the bacterial count. And fibre, fermented foods and a look at the cause might often achieve more than the next capsule.

What to expect in this article

  • What a probiotic is, and why the name reveals so much
  • Where studies show a benefit, with concrete numbers
  • Where the data get thin: healthy people and IBS
  • What the label says and what is in the capsule
  • The gut-immune axis through the KPNI lens
  • When the cause lies elsewhere
  • Who probiotics can be a risk for
  • Three levers that often achieve more than the next tub
Evidence labels in this article Clinical RCT or meta-analysis in humans   Human Observation, cohort, experiment in humans   In vivo Animal study   In vitro Laboratory or product analysis

Which form protects which microbes, whether spores, capsules or powder, is covered in depth in Probiotics: spore form or capsule. Here it is about the question that comes before: do you need one at all?

What is a probiotic, and why does the name reveal so much?

Many packs simply say Lactobacillus. Or bifidobacteria. That sounds precise. It is about as precise as the word dog.

A border collie herds sheep. A pug snores on the sofa. Both are dogs. Still, you would not send the pug out to herd sheep just because it is a dog too.

Bacteria are similar. The genus is the surname, the species the first name. Only the strain is the ID number. And only this ID number tells you which studies actually belong to your capsule.

How to read a probiotic name

LactobacillusGenus
rhamnosusSpecies
GGStrain

The studies on Lactobacillus rhamnosus GG apply to exactly this strain. Another strain of the same species can behave quite differently. In 2020, the genus Lactobacillus was split into 25 genera. Since then, Lactobacillus rhamnosus has been called Lacticaseibacillus rhamnosus, which is why you will find both old and new names on labels.

What a probiotic actually is was set out once more in 2014 by an international expert panel of the scientific association ISAPP. Probiotics are live microorganisms that, in adequate amounts, confer a health benefit. This sentence contains three conditions. They have to be alive. They have to arrive in sufficient amounts. And their benefit has to be demonstrated.

A yoghurt with live cultures meets the first condition. Whether it meets the other two is an open question. The panel explicitly calls for exactly this precision, so that doctors and consumers can tell the many products on the market apart.

Systematic review · 228 RCTs Strain by strain, disease by disease

In 2018, Lynne McFarland of the University of Washington and two colleagues sorted a total of 228 randomised trials by strain and by disease.

Against antibiotic-associated diarrhoea in adults, some precisely named Lactobacillus strains and mixtures showed an effect, while other Lactobacillus strains did not. Even well-studied strains such as Lactobacillus rhamnosus GG or Saccharomyces boulardii CNCM I-745 performed differently depending on the disease. The authors warn that meta-analyses lumping different probiotics together can lead to misleading conclusions.

For you this means: a result applies to one strain and one question. It does not automatically carry over to the next pack with a similar name.

McFarland LV, Evans CT, Goldstein EJC. Front Med (Lausanne). 2018;5:124. DOI: 10.3389/fmed.2018.00124

And it goes one level deeper. The same strain can perform differently in different people.

Meta-analysis · 12 RCTs · n=1,499 Same strain, different people

In 2015, a team led by Hania Szajewska at the Medical University of Warsaw pooled twelve trials on Lactobacillus rhamnosus GG against antibiotic-associated diarrhoea.

Overall, the risk fell from 22.4 to 12.3 percent. Looked at separately, however, the effect was significant only in children. In adults, it appeared only in a small group receiving antibiotics against Helicobacter pylori.

For you this means: it is not only the strain that counts, but also who takes it and what for.

Szajewska H, Kołodziej M. Aliment Pharmacol Ther. 2015;42(10):1149-1157. DOI: 10.1111/apt.13404
A shift in perspective

The question is not: probiotics, yes or no? The question is: which strain, for which problem, in which person?

If you ask it this way, sometimes you no longer need a capsule at all. Or you find exactly the one that fits your situation.

And now you know why the name on the label reveals more than any number next to it.

Where do probiotics show a genuine benefit in studies?

You have tonsillitis. The antibiotic is lying on the kitchen table. And with the pack comes the worry: what will this do to my gut?

Right here, in this narrow window of time, the evidence for probiotics is at its strongest. Antibiotics hit not only the pathogen but also many harmless residents of your gut. Diarrhoea is a common noticeable consequence.

8% vs 19%diarrhoea in children on antibiotics, with and without a probiotic (Cochrane, 33 trials)
1 in 65statistically, one case of C. difficile disease is avoided for every 65 people on antibiotics who take a probiotic
28 of 47trials in the latest Cochrane review with links to probiotic manufacturers
Cochrane · 33 RCTs · n=6,352 Children on antibiotics

In 2019, a Cochrane team led by Qin Guo of West China Second University Hospital in Chengdu analysed a total of 33 trials with 6,352 children.

With a probiotic, 8 percent developed diarrhoea, without one 19 percent. Nine children had to take a probiotic for one child to be spared diarrhoea. Doses of at least 5 billion colony-forming units per day performed better than lower ones, and the certainty of the evidence was moderate.

For you this means: here the benefit is measurable. The authors stress, however, that no firm conclusions can yet be drawn for products other than the well-studied ones.

Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Cochrane Database Syst Rev. 2019;4(4):CD004827. DOI: 10.1002/14651858.CD004827.pub5
Meta-analysis · 21 RCTs · n=4,780 The yeast among the probiotics

Saccharomyces boulardii is not a bacterium but a yeast. Antibiotics are aimed at bacteria, not at yeasts. In 2015, the Warsaw team led by Szajewska pooled a total of 21 trials with 4,780 children and adults.

The risk of diarrhoea on antibiotics fell from 18.7 to 8.5 percent, in children and adults alike. Against Clostridioides difficile, the effect was significant only in children, not in adults.

For you this means: a well-studied strain can make a measurable difference for a clear question. For a different question, the same product can perform less well.

Szajewska H, Kołodziej M. Aliment Pharmacol Ther. 2015;42(7):793-801. DOI: 10.1111/apt.13344

Clostridioides difficile, or C. difficile for short, is a gut bacterium that can spread after antibiotics. Its toxins can trigger severe inflammation of the large bowel. Here, a close look at the numbers pays off.

Cochrane · 47 RCTs · n=15,260 C. difficile: large relative, small absolute benefit

In 2025, a team led by Zahra Esmaeilinezhad and Bradley Johnston of Texas A&M University updated the Cochrane review on preventing C. difficile.

On probiotics, 1.6 percent fell ill, without them 3.2 percent. In relative terms that is a halving, in absolute terms a small step: 65 people have to take a probiotic for one case to be avoided, statistically. The authors rate the certainty of the evidence as low, and 28 of the 47 trials had links to manufacturers.

For you this means: relative numbers sound big, absolute ones are more honest. How much you gain depends heavily on your baseline risk. For people at low risk, the authors call for larger trials.

Esmaeilinezhad Z, Ghosh NR, Walsh CM et al. Cochrane Database Syst Rev. 2025;9(9):CD006095. DOI: 10.1002/14651858.CD006095.pub5

In 2020, the American Gastroenterological Association, AGA for short, drew conclusions from this. To prevent C. difficile during antibiotic treatment, it suggests only a few, precisely named options: Saccharomyces boulardii, the two-strain combination of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R, and two defined mixtures of three and four strains. It is a conditional recommendation, not an obligation.

On other questions, the same guideline is considerably more cautious. For children with acute gastroenteritis, it advises against probiotics. For IBS, Crohn's disease and ulcerative colitis, it recommends probiotics only in the context of clinical trials. It reserves specific combinations for pouchitis and for preterm infants with low birth weight, both of which belong in specialist hands.

And after the antibiotic?

Many people take a probiotic not only during but above all after a course of antibiotics. To rebuild the gut flora, so the idea goes. Less diarrhoea, however, does not yet mean that the flora recovers faster. That is a separate question.

Human and mouse · mucosal samples The finding from Rehovot

In 2018, Jotham Suez and the team at the Weizmann Institute examined the gut lining of volunteers and mice after a course of antibiotics, not just their stool.

With a multi-strain probiotic, the body's own gut flora returned with a marked delay and only partially. Without a probiotic, it recovered faster. With their own stool, collected before the antibiotics were given, it even returned almost fully within days. In the laboratory, soluble substances from the lactobacilli appeared to slow the growth of the body's own bacteria.

For you this means: a possible benefit after antibiotics might be cancelled out by a delayed recovery. The study was elaborate, with samples taken directly from the gut lining instead of only from stool.

Suez J, Zmora N, Zilberman-Schapira G et al. Cell. 2018;174(6):1406-1423.e16. DOI: 10.1016/j.cell.2018.08.047

In 2025, an international expert panel led by Hania Szajewska, which also included Jotham Suez, put this into sober perspective. Some clinical data suggest that probiotics can reduce side effects of antibiotics such as diarrhoea. However, there are no data that causally link this benefit to protection or recovery of the gut flora. Even the question of what a normal gut flora is, the panel notes, has not been answered uniformly.

How long recovery takes and what can slow it down is covered in depth in The gut after antibiotics. When diarrhoea after antibiotics needs a medical assessment is described in Clostridia in the gut.

A shift in perspective

Probiotics are most convincing like an umbrella for a forecast shower: a clear situation, a limited time, a known risk. As a permanent umbrella in sunshine, they do little.

And even in a shower, the umbrella has to suit exactly this weather. A strain with studies against diarrhoea on antibiotics is no evidence for anything else.

And now you know why probiotics are worth considering during a course of antibiotics, but are no free pass for the time afterwards.

Do probiotics do anything if you are healthy?

Maybe you do not take your probiotic because of an illness. But as a precaution. For your immune system, for your skin, for a good feeling in the morning.

That is an understandable wish. You want to do something for yourself. The only question is whether the capsule can fulfil this wish.

Meta-analysis · 22 RCTs · n=1,068 Healthy people, same diversity

In 2026, a team at Semmelweis University in Budapest analysed randomised trials in healthy people. The meta-analysis included 22 trials with 1,068 participants.

None of the common measures of gut flora diversity showed a significant difference from the comparison groups. Neither the bacterial family nor the duration of intake changed this. As early as 2016, a Copenhagen review had found greater diversity compared with placebo in none of seven trials.

For you this means: if you are healthy, the capsule did not make the gut flora more diverse in studies. This does not rule out other effects, but it does not demonstrate them either.

Éliás AJ, Földvári-Nagy KC, Al-Gharati YZ et al. BMC Med. 2026;24(1):71. DOI: 10.1186/s12916-025-04602-0 · Kristensen NB, Bryrup T, Allin KH et al. Genome Med. 2016;8(1):52. DOI: 10.1186/s13073-016-0300-5

Why is that? One possible answer comes from a sister study from the same laboratory in Israel.

Human and mouse · placebo-controlled The fully booked hotel

In 2018, Niv Zmora and the team at the Weizmann Institute gave volunteers either an eleven-strain probiotic or a placebo. They examined not only stool but also samples taken directly from the lining of the digestive tract.

The bacteria survived the passage. Whether they settled in the gut lining, however, varied greatly from person to person, could be predicted from the baseline microbiome and could not be seen in stool. The influence on the gut community remained temporary and individual.

For you this means: your gut is like a well-booked hotel. Whether a new guest gets a room is decided mainly by those already staying there.

Zmora N, Zilberman-Schapira G, Suez J et al. Cell. 2018;174(6):1388-1405.e21. DOI: 10.1016/j.cell.2018.08.041

Experts call this colonisation resistance. It is not a flaw in your body. It is the same property with which an intact gut flora can also compete with pathogens for space. From your immune system's point of view, a full, stable gut is a protective wall.

And in irritable bowel syndrome?

With IBS, the level of distress is often high. Bloating, cramps, changing stools, sometimes for years. No wonder many people reach for a probiotic first.

Meta-analysis · 82 RCTs · n=10,332 Many trials, little certainty

In 2023, a team led by Vivek Goodoory and Alexander Ford in Leeds updated its meta-analysis on probiotics in IBS: 82 trials with 10,332 people.

Only 24 trials had a low risk of bias in all domains. Individual strains and combinations showed signals for global symptoms, pain or bloating. The certainty of the evidence, however, was low to very low almost across the board.

For you this means: a time-limited trial can be reasonable. No promise can be derived from it.

Goodoory VC, Khasawneh M, Black CJ et al. Gastroenterology. 2023;165(5):1206-1218. DOI: 10.1053/j.gastro.2023.07.018

The guidelines reflect this uncertainty. The US society AGA recommends probiotics for IBS only in the context of clinical trials. A summary of the German S3 guideline by its authors stresses that there is no established standard therapy and that every therapy is initially a trial. There, probiotics are counted among the general measures that may be considered for all forms of IBS. Where bloating is the leading symptom, they show partly positive results in studies.

Before you try anything, a careful diagnosis is worthwhile. What can lie behind IBS symptoms is described in Irritable bowel: finding the causes.

And what about the placebo?

This is where the title of this article gets interesting. Because in IBS, many people who receive only a dummy pill also feel better.

Meta-analysis · 73 RCTs · n=8,364 on placebo The placebo response in IBS

In 2010, Alexander Ford and Paul Moayyedi analysed a total of 73 drug trials in IBS, with 8,364 people in the placebo groups.

On average, symptoms improved in 37.5 percent of those who received only a placebo. The rate was higher in European trials, with doctor-assessed outcomes and with shorter treatment duration.

For you this means: if you feel better on a probiotic, that experience is real. Whether it is down to the strain, however, cannot be said without a comparison. And an expensive placebo stays expensive.

Ford AC, Moayyedi P. Aliment Pharmacol Ther. 2010;32(2):144-158. DOI: 10.1111/j.1365-2036.2010.04328.x
A shift in perspective

A probiotic is more of a visitor than a new flatmate. Visitors can change an evening. The house is usually changed by those who live in it.

That is not bad news. It means: the strongest levers may not lie in the capsule, but in the conditions under which your own residents live.

And now you know why the capsule changes so little in healthy people, and why a trial in IBS can still be justifiable, with a clear goal and a clear end.

What does the label say, and what is in the capsule?

50 billion sounds like more than 5 billion. 20 strains sound like more than one. That is human. More feels like more protection.

On top of that comes a point many people are not aware of. In Germany, dietary supplements are legally classed as foods. Proof of efficacy and quality, as required for a medicine, is not mandatory before sale. Independent teams have therefore measured for themselves how well label and contents match.

Position paper · laboratory tests Discrepancies are not rare

In 2017, the probiotics working group of the European paediatric gastroenterology society ESPGHAN summarised quality tests from around the world.

Deviations from the label were surprisingly common. Strains were misidentified, microbes were not viable, the stated count could not be confirmed. Some products were contaminated, in some cases even with potential pathogens.

For you this means: the number on the pack is, first of all, a statement by the manufacturer. The experts call for it to hold true until the end of the shelf life.

Kolaček S, Hojsak I, Berni Canani R et al. J Pediatr Gastroenterol Nutr. 2017;65(1):117-124. DOI: 10.1097/MPG.0000000000001603
Product analysis · 16 products One in sixteen

A team at the University of California, Davis tested 16 probiotics for the bifidobacteria they contained, using genetic and culture methods.

Only one of the 16 products matched the label exactly in all samples. On top of that came differences from capsule to capsule and from batch to batch.

For you this means: even with a well-studied strain, you cannot be sure that exactly this strain is in your capsule. Quality is a part of the evidence that no label can replace.

Lewis ZT, Shani G, Masarweh CF et al. Pediatr Res. 2016;79(3):445-452. DOI: 10.1038/pr.2015.244

And the billions? The count is not entirely irrelevant. In the Cochrane review on children taking antibiotics, doses of at least 5 billion colony-forming units, CFU for short, per day performed better than lower ones. The crucial question is whether this can be generalised.

Review · dose and effect When more brings more

In 2017, A. C. Ouwehand, a researcher in the nutrition division of the DuPont group, reviewed human studies on whether higher probiotic doses achieve more.

For antibiotic-associated diarrhoea, a convincing dose-response relationship emerged. For C. difficile, IBS and many other targets, no clear relationship could be seen. The review explicitly stresses that missing data do not prove there is no effect.

For you this means: even in a review from industry, the formula more is better is supported for only a few questions. A high number does not turn an untested strain into a tested one.

Ouwehand AC. Benef Microbes. 2017;8(2):143-151. DOI: 10.3920/BM2016.0140
Loud label

What is often printed in large type

  • Bacterial count in billions
  • Number of strains included
  • General words like gut flora or immune system
  • Bacterial count at the time of manufacture
What counts for you

What you should look for

  • Genus, species and strain designation, in full
  • Human studies on exactly this strain and your question
  • The daily amount tested in these studies
  • Bacterial count until the end of the shelf life

Your label check in five questions

  • Is there a strain designation after the genus and species, meaning a code of letters or numbers?
  • Are there human studies on exactly this strain and exactly my question?
  • Does the daily amount match the amount used in these studies?
  • Does the stated count apply until the end of the shelf life?
  • Does the product suit my situation, for example with a weakened immune system, a catheter or a serious illness?

The team led by Eran Elinav and Eran Segal at the Weizmann Institute therefore calls for higher-quality evidence, more transparency, more education and better regulation of over-the-counter probiotics. That is not a rejection of probiotics. It is the wish that the pack says what the research can support.

A shift in perspective

The bacterial count is the volume. The strain is the song. Turning up the volume does not turn the wrong song into the right one.

If you take only one thing from this article, let it be this: look for the full name on the pack first. Only then is the number worth a look.

And now you know why, on a pack, I look for the strain name first and only then for the billions.

The gut-immune axis: why the soil can matter more than the seed

Maybe you are now wondering: if bacteria are so important, why do capsules change so little?

I look at this question through the lens of Clinical Psychoneuroimmunology, KPNI for short. It connects the nervous system, immune system, metabolism and hormones. And it suggests a thought: often, what matters most is not what you put into your gut. It is the conditions that prevail there.

Imagine your gut as a garden. Probiotics are seeds from a packet. Fibre, rhythm, rest and intact stomach acid are the soil. Seeds on concrete do not sprout, no matter how many you scatter.

A large part of your immune system sits in and beneath the gut lining. There, it learns every day to tell friend from foe. Gut bacteria support it in this, above all through what they produce from your food.

In vivo · mouse Butyrate and the peacemakers

In 2013, a team led by Yukihiro Furusawa at the RIKEN centre in Japan studied in mice how gut bacteria shape the immune system in the large intestine.

Butyrate, a fermentation product made by gut bacteria from fibre, promoted the formation of regulatory T cells. These cells can dampen inflammatory and allergic reactions. In mice with induced colitis, butyrate attenuated its development.

For you this means: in animal models, it is well documented that fermentation products from fibre can calm the immune system. In humans, this is biologically plausible but not demonstrated to the same degree.

Furusawa Y, Obata Y, Fukuda S et al. Nature. 2013;504(7480):446-450. DOI: 10.1038/nature12721

If fibre sets so much in motion, one question suggests itself: can you simply grow the bacteria from the capsule yourself?

Meta-analysis · 64 studies · n=2,099 Feeding instead of restocking

In 2018, a team led by Daniel So of Bond University in Australia pooled 64 controlled studies on fibre with 2,099 healthy adults.

With more fibre, bifidobacteria and lactobacilli in stool increased, and so did butyrate. This was clearest with fructans and galacto-oligosaccharides, as found for example in the onion family and in pulses. Overall diversity, by contrast, did not change.

For you this means: you can increase exactly the bacterial groups that many capsules aim to deliver. With foods that are already in your kitchen anyway.

So D, Whelan K, Rossi M et al. Am J Clin Nutr. 2018;107(6):965-983. DOI: 10.1093/ajcn/nqy041
RCT · n=36 · 17 weeks Fermented foods versus fibre

In 2021, a Stanford team led by Justin and Erica Sonnenburg and Christopher Gardner compared two diets over 17 weeks, each with 18 healthy adults.

Plenty of fermented foods such as yoghurt, kefir or kimchi steadily increased the diversity of the gut flora and lowered inflammatory markers in the blood. Plenty of fibre did not change diversity, but increased the bacterial enzymes that break down fibre. How the immune system responded depended on the diversity at the start.

For you this means: a small study, but a clear signal. Your kitchen might bring more diversity into your gut than a capsule.

Wastyk HC, Fragiadakis GK, Perelman D et al. Cell. 2021;184(16):4137-4153.e14. DOI: 10.1016/j.cell.2021.06.019

How you can feed your microbiome through your diet is covered in depth in Prebiotics: what feeds the microbiome and Fermented foods.

And then there is an axis that is often overlooked: your stress system.

Experiment · human · n=23 and n=13 When stress goes through the gut wall

Tim Vanuytsel and the team at the University of Leuven had healthy volunteers give a public speech and then measured how permeable their small intestine was.

The speech increased permeability, specifically in those whose cortisol rose markedly. The stress hormone CRH alone had the same effect. A mast cell stabiliser blocked it.

For you this means: your head has a say in your gut. No capsule can replace a nervous system that regularly finds its way out of alarm mode.

Vanuytsel T, van Wanrooy S, Vanheel H et al. Gut. 2014;63(8):1293-1299. DOI: 10.1136/gutjnl-2013-305690

Through the KPNI lens, four systems interlock here. The nervous system signals stress, and the hormonal system responds with CRH and cortisol. Mast cells of the immune system react to this, and the gut barrier can become more permeable. And the metabolism of your bacteria helps decide whether butyrate nourishes the gut lining and calms immune cells. A probiotic intervenes in this network at only one small point.

What a permeable gut barrier means and what of it can be measured is described in Leaky gut and zonulin.

A shift in perspective

You do not have to repopulate your gut. You can feed the residents who are already there.

That is less spectacular than 50 billion on a pack. But it works alongside you every day, with every meal and in every quiet minute.

A calm gut is not a luxury. It is freedom: going out to eat, travelling, keeping an appointment, without first having to know where the nearest toilet is. This freedom deserves more than a capsule taken on a hunch.

Shukri Jarmoukli, ViveCura Berlin

And now you know why, with gut problems, I ask about your plate, stress and rhythm first, and only then about a capsule.

When does the cause lie elsewhere?

You have tried three probiotics. Each for a few weeks. Your gut stays unsettled. And at some point you start to believe that your gut is just like that.

I see it differently. When several probiotics change nothing, that in itself is information. It says: look elsewhere.

From my clinical practice

What I clarify before I talk about a probiotic

In my practice, I often see people taking probiotics without anyone having looked for the cause of their symptoms beforehand. That is an observation from everyday practice, not a study.

That is why, for me, questions come first. Are there warning signs? Has coeliac disease been ruled out? Do you take medication such as acid blockers? How much stress are you carrying, how do you sleep, what do you eat on a normal day?

Only once these questions are answered do I ask whether a particular strain fits a particular situation. Sometimes the answer is yes. Often it is: not yet.

Small intestinal bacterial overgrowth

When bacteria multiply in the small intestine, where they do not belong in such numbers, additional microbes from capsules might rather worsen bloating, as a small observational study suggests. More on this in SIBO in the small intestine.

Stomach acid and acid blockers

Stomach acid is a gatekeeper against microbes from outside. In 1,815 people from three Dutch cohorts, taking acid blockers was associated with less diversity and with changes in 20 percent of bacterial groups. More in Low stomach acid.

Chronic stress

Via the stress axis, the gut barrier can become more permeable, as the Leuven experiment shows. Then regulating the nervous system is not a wellness extra but part of treating the gut.

Medication

It is not only antibiotics and acid blockers that change the gut. Which other drugs may play a role is described in Medication and the gut. Please never stop prescribed medication on your own.

Intolerances and coeliac disease

Lactose, fructose or gluten can trigger symptoms that look like IBS. Important: do not go gluten-free before you have been tested for coeliac disease, otherwise the test can come back falsely unremarkable. More in Recognising coeliac disease.

Unclear dysbiosis

A stool test can answer some questions, but not others. Which conclusions a reputable test can support is shown in Stool testing and PCR diagnostics.

Cohort · three cohorts · n=1,815 The underestimated gatekeeper

In 2016, Floris Imhann and a team at the University of Groningen examined the microbiome of 1,815 people from three cohorts, 211 of whom were taking acid blockers.

In them, diversity was lower, and their stool contained more bacteria that normally live in the mouth. At population level, the changes were more pronounced than those linked to antibiotics or other common medications.

For you this means: if you are thinking about probiotics, it is worth looking at the stomach too. An observational study, however, does not prove a cause, and a prescribed acid blocker is only changed under medical supervision.

Imhann F, Bonder MJ, Vich Vila A et al. Gut. 2016;65(5):740-748. DOI: 10.1136/gutjnl-2015-310376
When you should not experiment with probiotics Blood in your stool, black tarry stool, unintended weight loss, symptoms that wake you at night, fever, anaemia or a new, persistent change in your bowel habits from around the age of 45 need a medical assessment. The same applies to diarrhoea during or after a course of antibiotics that does not stop or comes with fever and severe abdominal pain. A probiotic is no substitute for diagnostics here, and please do not postpone a recommended colonoscopy.
A shift in perspective

A probiotic can make a symptom quieter. It does not answer the question of why.

Several unsuccessful attempts are therefore not a failure. They are a hint that the answer lies somewhere else.

And now you know why searching for the cause is often a more valuable step than the next product.

Who can probiotics be risky for?

Live bacteria, that sounds natural. But natural does not mean harmless. Especially not for everyone.

First, the reassuring side. For people without a weakened immune system who take a probiotic briefly alongside an antibiotic, the Cochrane authors see no increase in side effects. In the studies in children, no serious side effects attributed to the probiotics occurred. In seriously ill people, the picture looks different.

Cohort · genome analysis · intensive care From the capsule into the blood

A team led by Idan Yelin of the Technion in Haifa, together with doctors at Boston Children's Hospital, analysed five and a half years of intensive care covering 22,174 patients.

On a product containing Lactobacillus rhamnosus GG, 6 of 522 developed a bloodstream infection with lactobacilli, without the product 2 of 21,652. The bacteria in the blood were genetically indistinguishable from those in the capsule. In one patient, they carried a new mutation that conferred antibiotic resistance.

For you this means: in seriously ill people, a probiotic is not a harmless food. There, it calls for a careful medical weighing of benefits and risks.

Yelin I, Flett KB, Merakou C et al. Nat Med. 2019;25(11):1728-1732. DOI: 10.1038/s41591-019-0626-9

Severe acute pancreatitis

In a Dutch trial with 298 people, 16 percent died on a multi-strain probiotic, compared with 6 percent on placebo. Nine people in the probiotic group developed impaired blood flow to the bowel, eight of them with a fatal outcome.

RCT · Lancet 2008

Yeast probiotics in intensive care

In Madrid, three intensive care patients developed a fungal bloodstream infection. The only shared risk factor was a product containing Saccharomyces boulardii, and the genetic material was identical. After the product was withdrawn on the ward, the outbreak ended.

Case series · Clin Infect Dis 2005

Brain fog, gas and bloating

In a small US observational study, all 30 people with brain fog had been taking probiotics, often with small intestinal bacterial overgrowth and raised D-lactic acid. After stopping the probiotics and taking an antibiotic, the fog in the head disappeared in 23 of 30.

Observational study · 2018

Weakened immunity and catheters

The Cochrane authors point to observational studies with serious complications in severely debilitated or immunocompromised children, for example with a central venous catheter. Such risk groups need their own medical weighing of benefits and risks.

Cochrane 2019
When a probiotic belongs in medical hands With a weakened immune system, for example during chemotherapy or strong immunosuppression. With a central venous catheter. With a serious acute illness, in intensive care or with severe pancreatitis. In preterm infants. And if new symptoms such as grogginess or worse bloating appear while you are taking a probiotic: then talk to your doctor instead of increasing the dose.
A shift in perspective

The risk rarely lies in the capsule alone. It arises from capsule and situation together.

For most healthy people, the biggest risk is a different one: spending money on a hope and overlooking a cause in the process.

And now you know why the question is not only whether a probiotic is of benefit, but also who it suits.

Three levers that often achieve more than the next capsule

I deliberately give you no products and no doses. They depend on your situation, and I do not know it. What I give you are three directions you can put into practice today.

1

Feed what already lives in you

More plants, more variety: pulses, oats, vegetables, nuts, the onion family. In studies, fibre increased exactly the bifidobacteria and lactobacilli that many capsules aim to deliver. Increase slowly, because your gut needs time to get used to more fibre.

2

Put fermented foods on your plate

Plain yoghurt, kefir, sauerkraut from the chilled aisle, kimchi. In the Stanford study, gut flora diversity rose with fermented foods, and inflammatory markers fell. Start with small amounts, especially if you tolerate histamine poorly.

3

If a capsule, then with a reason, a name and an end date

Take a probiotic for a clear question, such as an increased risk of diarrhoea while on antibiotics. Choose a strain with studies on exactly that. Decide in advance how you will recognise a benefit and when you will take stock. If you have pre-existing conditions, discuss this with a doctor.

What is supported and what remains open

Well supported: Certain, precisely named strains can make diarrhoea on antibiotics less frequent, in children and adults. In seriously ill people, probiotics can trigger serious infections.

Plausible, with mixed or thin data: Individual strains might ease IBS symptoms. Fibre and fermented foods might have a favourable influence on the gut flora and the immune system, though some of the human studies on this are small. The path from butyrate to calmer immune cells has mainly been shown in animal models.

Open: Whether probiotics speed up the recovery of the gut flora after antibiotics. The most precise data tend to suggest otherwise.

My clinical perspective: Looking for the cause before reaching for a probiotic is my way of working in practice, not a study finding.

And now you know why

Probiotics are neither miracle remedies nor nonsense. They are tools with strain names. With the right name, for the right question and at the right time, they can make a difference.

Without all that, what often remains is an expensive placebo. And the chance that your gut, given food, rest and a clarified cause, can manage more than the shelf gives it credit for.

If you would like to have your gut symptoms assessed rather than only read about them: below this article you will find the option to book an appointment.

Frequently asked questions

Are probiotics worthwhile or a waste of money?

That depends on the situation, not on the pack. A benefit of certain strains against diarrhoea during a course of antibiotics is well supported: in a Cochrane review of 33 trials, children taking a probiotic developed diarrhoea in 8 percent of cases, compared with 19 percent without a probiotic. In healthy people, by contrast, probiotics did not measurably change the diversity of the gut flora in studies. In irritable bowel syndrome, the certainty of the evidence is mostly low. A probiotic therefore becomes worthwhile with a concrete question and a strain studied for exactly that question.

Which probiotics are the best studied?

Among the most frequently studied are Lactobacillus rhamnosus GG and the yeast Saccharomyces boulardii. For Saccharomyces boulardii, a meta-analysis of 21 trials found that the risk of diarrhoea on antibiotics fell from 18.7 to 8.5 percent. For Lactobacillus rhamnosus GG, the effect was clear in children, but not significant in adults overall. To prevent a Clostridioides difficile infection during antibiotic treatment, the US society AGA suggests only a few, precisely named strains and mixtures. Well studied therefore always means: for a specific question.

How do I recognise a good probiotic from the label?

By the full name. An informative label states the genus, species and strain designation, for example Lactobacillus rhamnosus GG and not just Lactobacillus. This includes the bacterial count at the end of the shelf life, not only at the time of manufacture. In addition, check whether there are human studies on exactly this strain and exactly your question. If the strain name is missing, no study can be reliably matched to the product.

Are more billions of bacteria better?

Not automatically. In the Cochrane review on children taking antibiotics, doses of at least 5 billion colony-forming units per day performed better than lower ones. A review of dose-response relationships, however, found a convincing relationship mainly for this type of diarrhoea, and no clear one for many other targets. A high number is also of little use if the strain has not been studied for your question or the microbes are no longer alive. The bacterial count is a statement of quantity, not a seal of quality.

Should I take a probiotic with an antibiotic?

That can be worthwhile, especially if your risk of diarrhoea is increased. The prevention studies mostly tested probiotics alongside the course of antibiotics. For the time afterwards, a study at the Weizmann Institute showed that a multi-strain probiotic delayed the return of the body's own gut flora. Less diarrhoea and faster recovery are therefore two different questions. If you have pre-existing conditions or a weakened immune system, it is best to discuss this with a doctor.

Do probiotics help with irritable bowel syndrome?

Some strains and mixtures might ease individual symptoms, but the data are uncertain. A meta-analysis from Leeds with 82 trials and 10,332 people rated the certainty of the evidence as low to very low almost across the board. The US society AGA recommends probiotics for irritable bowel syndrome only in the context of clinical trials. A summary of the German S3 guideline describes every treatment for irritable bowel syndrome as initially a trial and counts probiotics among the possible general measures. A careful diagnosis should come first, because other causes can lie behind similar symptoms.

Do probiotics settle in the gut permanently?

Mostly not. In a study at the Weizmann Institute, the bacteria of an eleven-strain product did survive the passage through the gut. Whether they settled in the gut lining, however, varied greatly from person to person and could not be seen in stool. The influence on the gut community was temporary and individual. A probiotic is therefore more of a visitor than a new flatmate.

Do probiotics do anything if I am healthy?

Measured by the diversity of your gut flora, probably not. A meta-analysis from Semmelweis University in Budapest with 22 trials and 1,068 healthy people found no significant change in diversity. As early as 2016, a Copenhagen review found greater diversity within the gut flora compared with placebo in none of seven trials. This does not rule out effects that are measured in other ways. As permanent insurance for healthy people, however, the capsule is poorly supported.

Are prebiotics and fibre the better choice?

For many people, they might be the more sensible first step. In a meta-analysis of 64 studies with 2,099 healthy adults, fibre increased bifidobacteria and lactobacilli in stool as well as butyrate, in other words exactly the residents that many capsules aim to deliver. In a Stanford study over 17 weeks, fermented foods increased the diversity of the gut flora and lowered inflammatory markers. It is best to increase fibre slowly. With irritable bowel syndrome or severe bloating, the choice belongs in individual advice.

Who can probiotics be dangerous for?

Above all for seriously ill people. In the intensive care units of a children's hospital in Boston, 6 of 522 patients on a product containing Lactobacillus rhamnosus GG developed a bloodstream infection with lactobacilli, compared with 2 of 21,652 without the product. In predicted severe pancreatitis, 16 percent died on probiotics and 6 percent on placebo in a Dutch trial. The probiotic yeast Saccharomyces boulardii has also been linked to fungal bloodstream infections in an intensive care unit. With a weakened immune system, a central venous catheter or a serious acute illness, any use belongs in medical hands.

Can probiotics trigger bloating or brain fog?

In some people that is possible, but it has not been well researched. In a small observational study from the USA, all 30 people with brain fog, bloating and gas had been taking probiotics. Small intestinal bacterial overgrowth and raised D-lactic acid were found more often in them. After the probiotics were stopped and antibiotic treatment was given, the brain fog disappeared in 23 of 30, and the abdominal symptoms improved markedly. A study like this does not prove a cause, but it is a reason to look more closely when new symptoms appear while taking probiotics.

How does this article differ from the one on spore form and capsules?

The article Probiotics: spore form or capsule compares delivery forms and goes through individual strain groups in detail. This article starts one level earlier: with the question of whether you need a probiotic at all, where the evidence holds up, what the market promises and when the cause of your symptoms lies elsewhere. The two texts complement each other. Once you have decided on a probiotic, the other article can help you choose the form.

Are yoghurt and kefir just as good as capsules?

They are not the same thing, but often the more practical route in everyday life. Fermented foods usually do not contain precisely defined strains in known amounts, which is why the capsule studies cannot be transferred to them. On the other hand, in a randomised Stanford study over 17 weeks, a diet rich in fermented foods increased the diversity of the gut flora and lowered inflammatory markers. If you tolerate histamine poorly, it is better to start with small amounts. For a targeted question such as diarrhoea on antibiotics, a studied strain in a defined amount is the more precise choice.

Further reading in the Supplements Guide

Related topics

SJ

Shukri Jarmoukli

Physician, Integrative Medicine · ViveCura Berlin

I combine conventional medicine with the perspective of Clinical Psychoneuroimmunology and lifestyle medicine. With probiotics, I ask first about the cause and the concrete question, and only then about the strain. What you read here is my reasoned position from research and practice, not the final word of science.

ViveCura, Skalitzer Straße 137, Berlin
This article does not replace medical advice or individual diagnostics.

Sources

All studies were researched via PubMed and checked against the PubMed metadata (title, authors, year, journal, DOI). Key papers were additionally cross-checked via Consensus, and individual figures come from the full texts in PubMed Central. The recommendations of the AGA guideline were checked against the society's own publication. The study type is given in square brackets.

  1. Hill C, Guarner F, Reid G et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. DOI: 10.1038/nrgastro.2014.66 [Consensus guideline, ISAPP expert panel]
  2. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716-729. DOI: 10.1038/s41591-019-0439-x [Review, perspective of the Weizmann Institute]
  3. McFarland LV, Evans CT, Goldstein EJC. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2018;5:124. DOI: 10.3389/fmed.2018.00124 [Systematic review with meta-analysis, 228 RCTs]
  4. Zheng J, Wittouck S, Salvetti E et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 2020;70(4):2782-2858. DOI: 10.1099/ijsem.0.004107 [Review article, taxonomy based on genome data]
  5. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149-1157. DOI: 10.1111/apt.13404 [Meta-analysis, 12 RCTs, n=1,499]
  6. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;4(4):CD004827. DOI: 10.1002/14651858.CD004827.pub5 [Meta-analysis, Cochrane, 33 RCTs, n=6,352]
  7. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015;42(7):793-801. DOI: 10.1111/apt.13344 [Meta-analysis, 21 RCTs, n=4,780]
  8. Esmaeilinezhad Z, Ghosh NR, Walsh CM, Steen JP, Burgman AM, Mertz D, Johnston BC. Probiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2025;9(9):CD006095. DOI: 10.1002/14651858.CD006095.pub5 [Meta-analysis, Cochrane, 47 RCTs, n=15,260]
  9. Su GL, Ko CW, Bercik P, Falck-Ytter Y, Sultan S, Weizman AV, Morgan RL. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 2020;159(2):697-705. DOI: 10.1053/j.gastro.2020.05.059 [Consensus guideline, AGA 2020]
  10. Suez J, Zmora N, Zilberman-Schapira G et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell. 2018;174(6):1406-1423.e16. DOI: 10.1016/j.cell.2018.08.047 [In vivo, mouse and human, mucosal samples]
  11. Szajewska H, Scott KP, de Meij T et al. Antibiotic-perturbed microbiota and the role of probiotics. Nat Rev Gastroenterol Hepatol. 2025;22(3):155-172. DOI: 10.1038/s41575-024-01023-x [Review, international expert panel]
  12. Éliás AJ, Földvári-Nagy KC, Al-Gharati YZ et al. Effect of probiotic supplementation on the gut microbiota diversity in healthy populations: a systematic review and meta-analysis of randomised controlled trials. BMC Med. 2026;24(1):71. DOI: 10.1186/s12916-025-04602-0 [Meta-analysis, 22 RCTs, n=1,068]
  13. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8(1):52. DOI: 10.1186/s13073-016-0300-5 [Systematic review, 7 RCTs]
  14. Zmora N, Zilberman-Schapira G, Suez J et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell. 2018;174(6):1388-1405.e21. DOI: 10.1016/j.cell.2018.08.041 [In vivo, mouse and human, placebo-controlled]
  15. Goodoory VC, Khasawneh M, Black CJ, Quigley EMM, Moayyedi P, Ford AC. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology. 2023;165(5):1206-1218. DOI: 10.1053/j.gastro.2023.07.018 [Meta-analysis, 82 RCTs, n=10,332]
  16. von Schassen H, Andresen V, Layer P. The new guideline on irritable bowel syndrome: what is new? Dtsch Med Wochenschr. 2021;146(19):1243-1248. DOI: 10.1055/a-1331-6478 [Review article, summary of the German S3 guideline on irritable bowel syndrome, article in German]
  17. Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther. 2010;32(2):144-158. DOI: 10.1111/j.1365-2036.2010.04328.x [Meta-analysis, 73 RCTs, n=8,364 in the placebo groups]
  18. Kolaček S, Hojsak I, Berni Canani R et al. Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2017;65(1):117-124. DOI: 10.1097/MPG.0000000000001603 [Review article, ESPGHAN position paper]
  19. Lewis ZT, Shani G, Masarweh CF et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79(3):445-452. DOI: 10.1038/pr.2015.244 [In vitro, product analysis, 16 products]
  20. Ouwehand AC. A review of dose-responses of probiotics in human studies. Benef Microbes. 2017;8(2):143-151. DOI: 10.3920/BM2016.0140 [Review, dose-response analysis, author from industry]
  21. Furusawa Y, Obata Y, Fukuda S et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446-450. DOI: 10.1038/nature12721 [In vivo, mouse]
  22. So D, Whelan K, Rossi M et al. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2018;107(6):965-983. DOI: 10.1093/ajcn/nqy041 [Meta-analysis, 64 studies, n=2,099]
  23. Wastyk HC, Fragiadakis GK, Perelman D et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.e14. DOI: 10.1016/j.cell.2021.06.019 [RCT, n=36, 17 weeks]
  24. Vanuytsel T, van Wanrooy S, Vanheel H et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut. 2014;63(8):1293-1299. DOI: 10.1136/gutjnl-2013-305690 [Pathophysiology, human experiment, n=23 and n=13]
  25. Imhann F, Bonder MJ, Vich Vila A et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740-748. DOI: 10.1136/gutjnl-2015-310376 [Cohort, three cohorts, n=1,815]
  26. Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol. 2018;9(6):162. DOI: 10.1038/s41424-018-0030-7 [Cohort, prospective observational study, n=38]
  27. Yelin I, Flett KB, Merakou C et al. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019;25(11):1728-1732. DOI: 10.1038/s41591-019-0626-9 [Cohort, genome analysis, intensive care unit, n=22,174]
  28. Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-659. DOI: 10.1016/S0140-6736(08)60207-X [RCT, n=298]
  29. Muñoz P, Bouza E, Cuenca-Estrella M et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11):1625-1634. DOI: 10.1086/429916 [Case series with literature review, intensive care unit]

This article is for information only and does not replace medical advice. It deliberately names no products and no doses for you. The study results apply to the strains, amounts and groups studied in each case and cannot be transferred to just any product. The statements on butyrate and regulatory T cells come from animal experiments and are biologically plausible in humans, but not yet supported to the same degree.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment